Prof. Xiangyu Zhong is a distinguished academician with a robust educational background in medicine. He serves as a Professor and Chief Physician in the Department of General Surgery at the Second Affiliated Hospital of Harbin Medical University. With extensive clinical expertise, he has significantly contributed to medical research, particularly in the fields of cholangiocarcinoma, Metabolic Associated Fatty Liver Disease (MAFLD), and hepatic ischemia-reperfusion injury. His academic journey is complemented by 57 publications in SCI/Scopus indexed journals, with a citation index of 1172, solidifying his position as a leading researcher in his field.
Prof. Zhong’s research is focused on cholangiocarcinoma, MAFLD, and hepatic ischemia-reperfusion injury. His work has substantially enhanced the understanding of these diseases, offering valuable insights into their pathogenesis and potential therapeutic approaches. With three ongoing research projects, his contributions continue to shape the future of clinical treatments and patient care in liver diseases. Although there are no consultancy or industry projects, Prof. Zhong’s research alone has garnered significant recognition, evidenced by his numerous publications and citation index. His contributions have directly impacted advancements in surgical techniques and liver disease management.
Prof. Zhong’s impactful research has led to significant advancements in understanding complex liver diseases such as cholangiocarcinoma, MAFLD, and hepatic ischemia-reperfusion injury. His work, which has been cited over 1,100 times, is widely recognized for providing new insights and therapeutic approaches that directly benefit patient care. The depth of his research has influenced both the scientific community and clinical practices, furthering knowledge in areas critical for the treatment of liver-related ailments. With a high citation index and numerous peer-reviewed publications, his work continues to drive innovation in liver surgery and related fields.
Publications:
Circ_0007534 Promotes Cholangiocarcinoma Stemness and Resistance to Anoikis through DDX3X-Mediated Positive Feedback Regulation of Parental Gene DDX42
Liu, S., Guan, C., Sha, X., Zhong, X., Jiang, X.
Cellular Signalling, 2024, 118, 111141
Open access
0 citations
Utilization of 3D Printing Technology in Hepatopancreatobiliary Surgery
Shi, W., Wang, J., Gao, J., Cui, Y., Zhong, X.
Journal of Zhejiang University: Science B, 2024, 25(2), pp. 123–134
Open access
1 citation
Forkhead Box O1 in Metabolic Dysfunction-Associated Fatty Liver Disease: Molecular Mechanisms and Drug Research
Sha, X., Zou, X., Liu, S., Zhong, X., Jiang, X.
Frontiers in Nutrition, 2024, 11, 1426780
Open access
1 citation
Research Progress and Applications of Epigenetic Biomarkers in Cancer
Gao, J., Shi, W., Wang, J., Zhong, X., Cui, Y.
Frontiers in Pharmacology, 2024, 15, 1308309
Open access
1 citation
Advances in Drug Therapy for Metastatic Pancreatic Ductal Adenocarcinoma
Gao, J., Wang, J., Guan, C., Xu, X., Zhong, X.
Journal of Cancer, 2024, 15(8), pp. 2214–2228
Open access
0 citations
Ferroptosis: New Strategies and Ideas for the Treatment of Pancreatic Ductal Adenocarcinoma
Yang, C., Dong, Q., Bao, H., Xu, Y., Zhong, X.
Frontiers in Bioscience – Landmark, 2024, 29(1), 45
Open access
0 citations
Cullin-Associated and Neddylation-Dissociated Protein 1 (CAND1) Alleviates NAFLD by Reducing Ubiquitinated Degradation of ACAA2
Huang, X., Liu, X., Li, X., Yang, B., Pan, Z.
Nature Communications, 2023, 14(1), 4620
Open access
5 citations
Retraction: The Prognostic Potential and Carcinogenesis of Long Non-Coding RNA TUG1 in Human Cholangiocarcinoma
Xu, Y., Leng, K., Li, Z., Jiang, X., Cui, Y.
Oncotarget, 2023, 14, pp. 779
Retraction
0 citations
Application of Normothermic Regional Perfusion in Controlled Donation After Cardiac Death Liver Transplant Donors
Zou, X., Huang, Z., Shi, W., Cui, Y., Zhong, X.
China Journal of General Surgery, 2023, 32(7), pp. 1087–1096
Open access
1 citation
Exosomal miRNAs in the Microenvironment of Pancreatic Cancer
Zou, X., Huang, Z., Guan, C., Xu, Y., Zhong, X.
Clinica Chimica Acta, 2023, 544, 117360
Open access
1 citation